| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant (2002) 17: 1-3
© 2002 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Diversity within the CLC chloride channel family involved in inherited diseases: from plasma membranes to acidic organelles
Faculté de Médecine, Xavier Bichat, Paris, France
Keywords: CLC chloride channels
Introduction
Since the first voltage-gated ClC-0 chloride channel was discovered by Jentsch et al. [1] in the marine ray Torpedo marmorata, nine chloride channels belonging to the CLC family have been identified in mammals [2]. These ClC channels exhibit marked differences in their tissue and cellular distribution. All ClC channels, except the ClC-1 channel [2], are expressed in mammalian kidneys. They have important functions, and mutations of some of them are responsible for inherited diseases. Furthermore, the development of ClC knockout mice models has produced a great deal of new information about the function(s) of these ClC channels and their pathological impact.
Expression and function of the kidney-specific ClC-K channels
Two closely homologous ClC chloride channels, referred to as rClC-K1 and rClC-K2 in rats and as hClC-Ka and hClC-Kb in humans [3,4], are almost exclusively expressed in kidney
Expression and function of the ClC-5 channel in Dent's disease
Expression and function of the other ClC channels
Conclusions
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Vanholder, D. Abramowicz, J. B. Cannata-Andia, V. Cocchi, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, S. Jenkins, et al. The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP) NDT Plus, June 1, 2009; 2(3): 213 - 221. [Full Text] [PDF] |
||||
![]() |
S. Zitta, H. Holzer, G. Reibnegger, and W. Estelberger Comment on 'Comparison between creatinine and cystatin C-based GFR equations in renal transplantation' Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1764 - 1764. [Full Text] [PDF] |
||||
![]() |
A. Carbone, A. Gloghini, and G. Dotti EBV-Associated Lymphoproliferative Disorders: Classification and Treatment Oncologist, May 1, 2008; 13(5): 577 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iseki and M. Tozawa Reply Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1412 - 1413. [Full Text] [PDF] |
||||


